BR100 Decreased By (-0.19%)
BR30 Decreased By (-0.37%)
KSE100 Decreased By (-0.21%)
KSE30 Decreased By (-0.28%)
AGHA 6.64 Increased By ▲ 0.03 (0.45%)
BECO 4.22 Increased By ▲ 0.01 (0.24%)
BML 53.35 Decreased By ▼ -2.10 (-3.79%)
BOP 28.82 Increased By ▲ 0.21 (0.73%)
CNERGY 12.29 Decreased By ▼ -0.12 (-0.97%)
CSIL 5.68 Increased By ▲ 0.70 (14.06%)
FCCL 51.78 Increased By ▲ 0.74 (1.45%)
FFL 13.93 Increased By ▲ 0.14 (1.02%)
FNEL 1.10 Decreased By ▼ -0.01 (-0.9%)
KEL 5.85 Decreased By ▼ -0.04 (-0.68%)
KOSM 5.50 Increased By ▲ 0.22 (4.17%)
LOTCHEM 26.06 Decreased By ▼ -0.24 (-0.91%)
MLCF 90.06 Increased By ▲ 0.67 (0.75%)
NBP 156.14 Increased By ▲ 0.96 (0.62%)
NCPL 49.27 Decreased By ▼ -0.78 (-1.56%)
NPL 52.80 Decreased By ▼ -1.03 (-1.91%)
OGDC 298.96 Decreased By ▼ -1.43 (-0.48%)
PACE 9.61 Increased By ▲ 0.03 (0.31%)
PAEL 33.50 Increased By ▲ 0.20 (0.6%)
PIBTL 13.77 Increased By ▲ 0.16 (1.18%)
PPL 217.43 Increased By ▲ 0.40 (0.18%)
PRL 93.19 Decreased By ▼ -0.26 (-0.28%)
PTC 51.99 Decreased By ▼ -5.19 (-9.08%)
SSGC 22.58 No Change ▼ 0.00 (0%)
TBL 9.26 Increased By ▲ 0.07 (0.76%)
TELE 7.05 Decreased By ▼ -0.01 (-0.14%)
TPL 20.76 Decreased By ▼ -0.02 (-0.1%)
TPLP 12.10 Decreased By ▼ -0.20 (-1.63%)
TREET 23.87 Decreased By ▼ -0.22 (-0.91%)
TRG 53.94 Decreased By ▼ -0.10 (-0.19%)
Business & Finance

GSK Pakistan appoints Erum Shakir as new CEO

CEO of GSK Aziz ul Haq has reigned from his post citing family commitments. Erum has also served on the Board
Published Updated
  • CEO of GSK Aziz ul Haq has reigned from his post citing family commitments.
  • Erum has also served on the Board of Directors in GSK Pakistan and Bangladesh in her previous roles, informed the company.

 

Pharmaceutical giant, GlaxoSmithKline (GSK) Pakistan Limited has appointed Erum Shakir Rahim as new Chief Executive Officer (CEO) of the company, it was learnt on Thursday.  

“This is to inform the shareholders that Mr. Aziz Ul Haq Chief Executive Officer of GlaxoSmithKline Pakistan Limited has resigned to join his family in Australia. The Board of Directors has accepted his resignation with effect from March 01, 2020,” read a company’s’ notification issued at the Pakistan Stock Exchange (PSX).

The incoming CEO Erum Shakir Rahim is currently as General Manager, GSK Indonesia Pharma Emerging. The company said that Rahim “has a strong track record of success in multiple GM roles within GSK in Malaysia, Bangladesh and Indonesia.

The company informed that Erum contributed to “GSK Pakistan’s market leading position in the country with 12 percent market share and eight GSK brands in the top 20 by launching 20 new assets across several therapy areas as well as leading critical business development initiatives.”

Erum has also served on the Board of Directors in GSK Pakistan and Bangladesh in her previous roles, informed the company.

Comments

Comments are closed for this article.